Whole-body hyperthermia, as used in HEATT therapy, raises the body’s temperature to a therapeutic level, making it suitable for systemic conditions. Localized or regional hyperthermia, on the other hand, targets heat to a specific tumor or area, focusing only on the isolated cancer/Tumor sites. Localized and regional methods don’t address cancers spread to the bloodstream, nor can they safely reach an internal temperature of 42°C (107.6°F). HEATT therapy, validated by our FDA-approved clinical trials, is the only whole-body hyperthermia treatment proven to achieve this temperature safely and effectively across the entire body.